Microbot Medical Inc.
MBOT
$4.03
$0.14633.77%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -21.77% | -13.79% | -6.55% | -5.87% | 10.08% |
Total Depreciation and Amortization | -21.65% | -28.44% | -14.15% | -3.85% | -11.01% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -73.24% | -67.25% | -60.89% | 148.76% | 117.84% |
Change in Net Operating Assets | 276.35% | 204.21% | 187.44% | -1,147.27% | -73.59% |
Cash from Operations | -26.03% | -19.75% | -3.45% | 2.38% | 25.03% |
Capital Expenditure | 29.27% | 48.94% | 24.24% | 66.67% | -156.25% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -200.00% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -7,561.89% | -923.99% | -22.13% | 164.13% | 115.23% |
Cash from Investing | -8,637.98% | -903.14% | -22.10% | 163.31% | 113.23% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 705.70% | 265.79% | 18.11% | -53.78% | -59.51% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 735.80% | 272.36% | 21.01% | -53.10% | -60.97% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 149.82% | 307.79% | 32,400.00% | 71.82% | -103.25% |